Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-69,000
Closed -$1.67M 4961
2024
Q3
$1.67M Hold
69,000
﹤0.01% 2856
2024
Q2
$1.2M Buy
69,000
+37,000
+116% +$651K ﹤0.01% 3065
2024
Q1
$513K Buy
+32,000
New +$674K ﹤0.01% 3475
2021
Q4
Sell
-2,500
Closed -$263K 5761
2021
Q3
$263K Hold
2,500
﹤0.01% 4435
2021
Q2
$442K Hold
2,500
﹤0.01% 4098
2021
Q1
$334K Buy
+2,500
New +$387K ﹤0.01% 3667

Other funds holding ZLAB

David Shaw's ZLAB Position: Q2 2026 in Review

David Shaw increased its Zai Lab (ZLAB) stake by 123% in Q2 2026, buying an estimated $1.54M and bringing the position to 141,158 shares worth $2.68M. The position accounts for ﹤0.01% of the portfolio, ranked #2949.

David Shaw first reported a position in ZLAB in Q4 2017 and has held it in 30 quarters since. The position peaked at $30.7M in Q4 2020. 93 funds tracked by Wall St. Rank hold ZLAB as of Q2 2026.

  • David Shaw held 141,158 shares of Zai Lab worth $2.68M as of Q2 2026.
  • David Shaw bought 77,915 Zai Lab shares in Q2 2026, an estimated $1.54M.
  • Zai Lab made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #2949 holding.
  • David Shaw first reported a position in Zai Lab in Q4 2017 and has held it in 30 quarters since.
  • David Shaw's Zai Lab position peaked at $30.7M in Q4 2020.
  • 93 funds tracked by Wall St. Rank held Zai Lab as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.